TGFB1 and oral submucous fibrosis: These findings suggest that naringenin not only protects cells from cytotoxic damage but also exerts antifibrotic effects by modulating critical pathways like TGF-β, highlighting its therapeutic potential for fibrotic conditions such as oral submucous fibrosis (OSMF).